[link removed] [link removed] [link removed] [link removed] [link removed]

Email not displaying correctly? View it in your browser. ([link removed])

[link removed]
Issue 1,717: October 4, 2023
Top Stories
* CDC issues updated 2023 child and adult recommended immunization schedules, adding addenda listing new 2023 recommendations (#IZX1)
* CDC and CMS issue letter encouraging prevention of RSV this season with newly recommended vaccines and monoclonal antibody (#IZX2)
* October 5 is World Meningitis Day. Vaccination prevents meningococcal meningitis. (#IZX3)
* “Pregnancy and Flu Vaccine”: watch the 1-minute answer, part of the Ask the Experts Video Series on Facebook, LinkedIn, X (Twitter), YouTube, and Instagram  (#IZX4)
* Institute for Safe Medication Practices highlights potential for dosing error with Fluzone high-dose vaccine  (#IZX5)
* IZ Express keeps 55,000+ readers up to date on what’s new in vaccines each week; invite your colleagues to subscribe! (#IZX6)
* Spotlight: Immunize​.org resources focused on adolescent vaccination (#IZX7)
* Vaccines in the news (#IZX8)


Immunize​.org Pages and Handouts
* Recap: Immunize​.org updated these clinical resources in August and September (#IZX9)


Vaccine Information Statements
* Reminder! Immunize​.org posts 28 new translations of Vaccine Information Statement for RSV vaccine for older adults. (#IZX10)
* Recap: Vaccine Information Statements and translations released in August and September (#IZX11)


Featured Resources
* National Network of Immunization Coalitions’ webinar, “What You Need to Know about New RSV Immunizations for Children and Adults,” available for on-demand viewing  (#IZX12)
* Public Health Foundation and CDC create three videos to help clinicians differentiate “expiration date” and “beyond use date” for vaccines (#IZX13)
* Public Health Communications Collaborative offers social media graphics and messages to communicate key details about respiratory illness prevention (#IZX14)
* Explore the www.Give2MenACWY​.org website to increase coverage for the MenACWY booster and other adolescent vaccinations (#IZX15)


Notable Publications
* “COVID-19 Vaccination Recommendations and Practices for Women of Reproductive Age, by Health Care Providers—Fall DocStyles Survey, United States, 2022” published in MMWR (#IZX16)
* “Inequities in COVID-19 Vaccination Coverage among Pregnant Persons, by Disaggregated Race and Ethnicity—Massachusetts, May 2021–October 2022” published in MMWR (#IZX17)
* “Effectiveness of Maternal mRNA COVID-19 Vaccination during Pregnancy against COVID-19–Associated Hospitalizations in Infants Aged <6 Months during SARS-CoV-2 Omicron Predominance—20 States, March 9, 2022–May 31, 2023” published in MMWR (#IZX18)
* “Influenza, Tdap, and COVID-19 Vaccination Coverage and Hesitancy among Pregnant Women—United States, April 2023” published in MMWR (#IZX19)


Upcoming Events
* Today! Virtual: CDC briefing on fall and winter virus season with CDC Director Mandy K. Cohen on October 4 at 12:00 p.m. (ET).   (#IZX20)


Editorial Information (#Editorial)
------------------------------------------------------------
Top Stories
------------------------------------------------------------
CDC issues updated 2023 child and adult recommended immunization schedules, adding addenda listing new 2023 recommendations

Acting ahead of its annual February publication cycle, CDC issued updated 2023 recommended immunization schedules. The additional page (addendum) on each schedule summarizes recommendations adopted earlier in 2023. The updated documents include:
* Recommended Child and Adolescent Immunization Schedule ([link removed]) , United States, 2023
* Recommended Adult Immunization Schedule ([link removed]) , United States, 2023

By publishing updated official schedules now, CDC is able to reduce the time between new recommendations and insurance coverage for the new recommendations, as required by the Affordable Care Act. The updated schedules highlight changes with red markings. The addenda summarize new recommendations published since February 2023 for the prevention of COVID-19, RSV, poliovirus, and influenza.
[link removed]

Back to top (#Top)

------------------------------------------------------------
CDC and CMS issue letter encouraging prevention of RSV this season with newly recommended vaccines and monoclonal antibody

CDC and the Centers for Medicare and Medicaid Services (CMS) issued a letter to public health partners to raise awareness of the new prevention tools available to protect babies and older adults from illness and complications related to respiratory syncytial virus (RSV). The letter explains funding options for the monoclonal antibody and vaccines.

The letter explains the availability of the long-acting monoclonal antibody, nirsevimab (Beyfortus, Sanofi/AstraZeneca), and two RSV vaccines (Arexvy, GSK, and Abrysvo, Pfizer). The recommendations for these products appear in the addenda of the revised 2023 child and adolescent immunization schedule ([link removed]) and adult immunization schedule ([link removed]) .

For Children:
* Nirsevimab will be covered by Medicaid and the Children’s Health Insurance Program (CHIP) for children, with children enrolled in Medicaid generally receiving nirsevimab doses through the VFC program
* The maternal RSV vaccine (Abrysvo) will be included in the VFC program for pregnant people younger than age 19 years

For Adults:
* State Medicaid agencies will be required to cover Arexvy and Abrysvo without cost-sharing for nearly all full-benefit beneficiaries age 19 and older who are covered under traditional Medicaid if the ACIP recommendations apply
* State separate CHIP programs will also be required to cover both RSV vaccines without cost-sharing for enrollees age 19 and older if the ACIP recommendations apply
* Both RSV vaccines must be covered without cost sharing by Medicare Part D Plans

For Both Children and Adults:
* Most private health insurers must cover these immunization products without cost sharing, starting with plan years beginning on or after the date that is one year after the ACIP recommendation is adopted by the CDC Director
* Similarly, Medicaid alternative benefit plans (ABPs) must also cover these products without cost-sharing for adults age 21 and older beginning on that same date
* Until that point, private insurers will be making choices about coverage and reimbursement for these immunization products subject to applicable state law, as will Medicaid state agencies operating ABPs

Related Links
* CDC: recommended child and adolescent immunization schedule ([link removed]) , United States, 2023
* CDC: recommended adult immunization schedule ([link removed]) , United States, 2023

Back to top (#Top)
------------------------------------------------------------
October 5 is World Meningitis Day. Vaccination prevents meningococcal meningitis.

World Meningitis Day ([link removed]) , organized by the Confederation of Meningitis Organisations ([link removed]) (CoMO), is observed on October 5.

Meningococcal disease ([link removed]) , any illness caused by Neisseria meningitidis, includes infections of the lining of the brain and spinal cord (meningitis) and bloodstream (sepsis). These infections are often severe and can be deadly.

CDC recommends routine Meningococcal ACWY (MenACWY) ([link removed]) vaccination for all preteens age 11–12 years with a booster at age 16 years. Meningococcal B (MenB) ([link removed]) vaccination is recommended for individuals age 10 years or older at increased risk for meningococcal disease and for others age 16 through 23 years who want protection, through shared clinical decision making ([link removed]) . Keeping up to date with recommended vaccines is the best protection against meningococcal disease.

[link removed]

To encourage sharing information about the signs and symptoms of meningitis, CoMO created a toolkit ([link removed]) , free to download and share. Use the hashtag #DefeatMeningitis in your social media postings.

Visit the websites of these three parent-led, nonprofit partner organizations:
* Meningitis B Action Project ([link removed])
* Meningitis Angels ([link removed])
* National Meningitis Association ([link removed]) (archived)

Related Links
* CoMO: World Meningitis Day ([link removed]) toolkit ([link removed]) main page
* WHO: Defeating Meningitis by 2030 ([link removed]) web page
* WHO: Meningitis Disease ([link removed]) web page
* CDC: Meningococcal Vaccination ([link removed]) web page
* Immunize.org: Vaccines: Meningococcal ACWY (MenACWY) ([link removed]) main page
* Immunize.org: Ask the Experts: Meningococcal ACWY ([link removed]) web page
* Immunize.org: Give2MenACWY.org ([link removed]) website
* Immunize.org: Vaccines: Meningococcal B (MenB) ([link removed]) main page
* Immunize.org: Ask the Experts: Meningococcal B ([link removed]) web page

Back to top (#Top)
------------------------------------------------------------
“Pregnancy and Flu Vaccine”: watch the 1-minute answer, part of the Ask the Experts Video Series on Facebook, LinkedIn, X (Twitter), YouTube, and Instagram 

Immunize​.org's social media channels make it easy for you to learn a little more every day. This week, our featured episode from the Ask the Experts Video Series is Pregnancy and Flu Vaccine ([link removed] ) . This is available on our YouTube channel ([link removed]) , along with our full collection of quick video answers to popular Ask the Experts ([link removed]) questions.

[link removed]

Like, follow, and share Immunize​.org’s social media accounts and encourage colleagues and others interested in vaccination to do likewise:
* Facebook at ImmunizeOrg ([link removed])
* Instagram at ImmunizeOrg ([link removed])
* LinkedIn at Immunize.org ([link removed])
* X (Twitter) at ImmunizeOrg ([link removed])
* YouTube at ImmunizeOrg ([link removed])

Back to top (#Top)
------------------------------------------------------------
Institute for Safe Medication Practices highlights potential for dosing error with Fluzone high-dose vaccine

In the September 7 issue of its subscriber newsletter, the Institute for Safe Medication Practices ([link removed]) (ISMP) published a safety brief on a potential for confusion about dosing caused by the packaging of Fluzone High-Dose Quadrivalent Vaccine ([link removed]) . An excerpt from the article appears below.

We received a report about this year’s FLUZONE (influenza) high-dose quadrivalent vaccine for adults 65 years and over by Sanofi Pasteur. The carton's primary display panel states it contains 10 single-dose prefilled syringes–five trays with two syringes sealed in one tray. The concern is that some may think both syringes are needed to administer a dose. If your organization purchases this vaccine, notify staff and ensure barcode scanning is used when dispensing and administering. Consider adding auxiliary labels to each tray noting that each dose requires only one syringe. If stored outside the carton, consider removing the syringes from each tray.

ISMP published a follow-up story in its September 21 subscriber newsletter describing a report in which a patient was given two injections at one visit. If your organization purchases this vaccine, consider taking these actions:
* Notify staff about the potential for errors and remind them only one injection is needed
* Ensure barcode scanning is used where available
* Either dispense as a unit dose syringe or, if the entire carton must be dispensed, add auxiliary labels noting that each dose requires only one syringe

Related Links
* Institute for Safe Medication Practices website ([link removed])
* ISMP: Healthcare Practitioner’s Vaccine Error Reporting Form ([link removed]) web page
* CDC: Fluzone High-Dose Seasonal Influenza Vaccine ([link removed]) main page
* FDA: Fluzone High-Dose Quadrivalent ([link removed]) package insert ([link removed]) (PDF)
* Immunize​.org: Don’t Be Guilty of These Preventable Errors in Vaccine Administration! ([link removed]) (PDF)
* Immunize​.org: Don’t Be Guilty of These Preventable Errors in Vaccines Storage and Handling! ([link removed]) (PDF)

Back to top (#Top)
------------------------------------------------------------
IZ Express keeps 55,000+ readers up to date on what’s new in vaccines each week; invite your colleagues to subscribe!

Encourage your coworkers to subscribe to ([link removed]) IZ Express ([link removed]) ([link removed]) so they get all the news that matters to vaccinators in their own inbox each Wednesday. IZ Express ([link removed]) , the weekly e-newsletter produced by Immunize​.org, alerts 55,000+ readers to the week’s important vaccine developments. IZ Express also features:
* Educational materials from Immunize​.org, CDC, AAP, and others
* Newly posted Vaccine Information Statements and their translations
* Notices about online and in-person educational opportunities, many offering free continuing education credit

[link removed] [link removed]

We appreciate you as a subscriber! Thank you for helping us spread the latest vaccine news.
Back to top (#Top)
------------------------------------------------------------
Spotlight: Immunize​.org resources focused on adolescent vaccination

Immunize​.org offers many useful materials on adolescent vaccination for professionals and parents.

Resources for Adolescent Vaccination ([link removed]) main page highlights all the adolescent educational materials from Immunize.org and partner organizations.

Adolescent Vaccination ([link removed]) main page contains the handouts that pertain to adolescent vaccinations.

CDC Schedules ([link removed]) main page provides print-ready PDFs of the recommended vaccination schedules for children and adolescents, as well as for adults.

Screening Checklists about Vaccine Contraindications and Precautions ([link removed]) main page links you to forms that patients can fill out to expedite assessment of vaccination needs and contraindications.

Give2MenACWY ([link removed]) website offers resources to help providers increase teen vaccination and MenACWY booster dose rates.
Back to top (#Top)
------------------------------------------------------------
Vaccines in the news

These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
* Forbes: Vaccine Misinformation Spilling Over to Pets Puts Us All at Risk ([link removed] ) (9/26/23)
* USA Today: Are COVID Vaccine Concerns Impacting Flu-Shot Rates? Here’s What the Data Says. ([link removed]) (9/22/23)
* Nature: Vaccine Specialist Peter Hotez: Scientists Are ‘Under Attack for Someone Else’s Political Gain’ ([link removed] ) [link removed](9/21/23)

Back to top (#Top)
------------------------------------------------------------
Immunize​.org Pages and Handouts
------------------------------------------------------------
Recap: Immunize​.org updated these clinical resources in August and September

IZ Express regularly summarizes Immunize​.org’s new and updated educational materials and web pages. All Immunize​.org materials are free to distribute. In recent weeks, Immunize​.org updated or created new helpful materials:

Immunize.org Materials for Clinicians
* Brand New Resources
+ Addressing Vaccination Anxiety in Adolescents and Adults: Strategies for Healthcare Professionals ([link removed])
+ Addressing Vaccination Anxiety for Children Strategies: for Healthcare Professionals ([link removed])
+ Addressing Vaccination Anxiety for Infants and Toddlers: Strategies for Healthcare Professionals ([link removed])
+ Vaccination-Related Syncope: Information for Healthcare Personnel ([link removed])
+ Implementing Hepatitis B Universal Adult Screening and Vaccination: Clinical Answers for Healthcare Professionals ([link removed])
* Influenza
+ Influenza Vaccine Products for the 2023–2024 Influenza Season ([link removed])
+ Guide for Determining the Number of Doses of Influenza Vaccine to Give to Children Age 6 Months through 8 Years ([link removed])
+ Standing Orders for Administering Influenza Vaccine to Adults ([link removed])
+ Standing Orders for Administering Influenza Vaccine to Children and Teens ([link removed])
+ Screening Checklist for Contraindications to Injectable Influenza Vaccination ([link removed])
+ Screening Checklist for Contraindications to Live Attenuated Intranasal Influenza Vaccination ([link removed])
+ How to Administer Intramuscular and Intranasal Influenza Vaccines ([link removed])
+ Talking with Your Patient about Contraindications and Precautions to Influenza Vaccination ([link removed])
+ Communicating the Benefits of Influenza Vaccination ([link removed])
+ Declination of Influenza Vaccination ([link removed])
* Other Screening Checklists
+ Screening Checklist for Contraindications to Vaccines for Adults ([link removed])
+ Screening Checklist for Contraindications to ([link removed]) Vaccines for Children and Teens ([link removed])
+ Screening Checklist for Contraindication to ([link removed]) HPV, MenACWY, MenB, and Tdap Vaccines for Teens ([link removed])
* Other Vaccine Administration Resources
+ Before You Vaccinate Adults, Consider Their "H-A-L-O"! ([link removed])
+ Vaccines with Diluents: How to Use Them ([link removed])
+ Vaccine Administration Record for Adults ([link removed])
+ Vaccine Administration Record for Children and Teens ([link removed])
+ Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools ([link removed])
+ Don’t Be Guilty of These Preventable Errors in Vaccine Administration ([link removed])
+ Notification of Immunization Letter Template ([link removed])
* Hepatitis B Vaccination and Testing
+ Hepatitis B and Healthcare Personnel ([link removed])
+ Hepatitis B Facts: Testing and Vaccination ([link removed])

Immunize.org Printable Materials for Patients
* Brand New Resources
+ Addressing Vaccination Anxiety in Adolescents and Adults: Strategies for Vaccine Recipients and Caregivers ([link removed])
+ Addressing Vaccination Anxiety for Children: Strategies for Vaccine Recipients and Caregivers ([link removed])
+ Addressing Vaccination Anxiety for Infants and Toddlers: Strategies for Parents and Caregivers ([link removed])
+ Fainting Related to Vaccination: What You Need to Know ([link removed])
+ Hepatitis B Vaccination and Screening of Adults: Simple Steps to Protect Yourself from Serious Liver Disease ([link removed])
* Q&A Diseases and Vaccines: Hepatitis A ([link removed]) , Measles ([link removed]) , Mumps ([link removed]) , Rubella ([link removed]) , and Varicella ([link removed])
* Influenza
+ Not Sure If You Can Get an Influenza Vaccine? ([link removed])
+ Don’t Take Chances with Your Family’s Health—Make Sure You All Get Vaccinated Against Influenza Every Year! ([link removed])
* Hepatitis A Is a Serious Liver Disease: Vaccination Can Protect You! ([link removed])

Immunize.org Web Pages
* New! Addressing Vaccination Anxiety ([link removed])
* Vaccine Timeline ([link removed])
* Immunization Requirements for Childcare, School, and College: State Websites and Resources
+ State Requirements by Vaccine ([link removed])
+ Exemptions Permitted for State Childcare and School (Kg–Gr 12) Immunization Requirements ([link removed])
+ State Health Departments ([link removed])
* Ask the Experts:
+ Hepatitis B ([link removed])
+ Influenza ([link removed])
+ Meningococcal ACWY ([link removed])
+ Polio ([link removed])
+ Storage and Handling ([link removed])
+ Travel Vaccines ([link removed])

Related Links
* Immunize​.org: Handouts ([link removed]) main page to see educational materials sorted by category
* Immunize​.org: Ask the Experts ([link removed]) main page to access more than 1,200 questions answered by Immunize.org experts
* Immunize​.org: Clinic Tools ([link removed]) main page and its nine subtopics
* Immunize​.org: Educational Materials for Patients and Staff ([link removed]) —an alphabetical list of more than 240 ready-to-print staff educational materials and patient handouts

Back to top (#Top)
------------------------------------------------------------
Vaccine Information Statements
------------------------------------------------------------
Reminder! Immunize​.org posts 28 new translations of Vaccine Information Statement for RSV vaccine for older adults.

Immunize​.org posted 28 new translations of the Vaccine Information Statement (VIS) for respiratory syncytial virus (RSV) vaccination ([link removed]) of adults age 60 years or older using shared clinical decision-making. These translations join the Spanish ([link removed]) (RTF ([link removed]) ) VIS.

All translations are available in print-ready PDF format.

[link removed] [link removed]
Respiratory Syncytial Virus (RSV) Vaccine VIS: (view in English ([link removed]) ):

Arabic ([link removed]) Khmer ([link removed])
Armenian ([link removed]) Korean ([link removed])
Bengali ([link removed]) Pashto ([link removed])
Burmese ([link removed]) Polish ([link removed])
Chinese–Simplified ([link removed]) Portuguese ([link removed])
Chinese–Traditional ([link removed]) Russian ([link removed])
Farsi ([link removed]) Somali ([link removed])
French ([link removed]) Swahili ([link removed])
German ([link removed]) Tagalog ([link removed])
Haitian Creole ([link removed]) Thai ([link removed])
Hindi ([link removed]) Ukrainian ([link removed])
Hmong ([link removed]) Urdu ([link removed])
Italian ([link removed]) Vietnamese ([link removed])
Japanese ([link removed]) Yiddish ([link removed])

Related Links
* Immunize​.org: Respiratory Syncytial Virus (RSV) VIS ([link removed]) main page
* Immunize​.org: Respiratory Syncytial Virus (RSV) Vaccine VIS ([link removed]) (PDF, English)
* Immunize​.org: Vaccine Information Statements main page ([link removed]) with VISs in up to 47 languages ([link removed])
* CDC: What's New with VISs ([link removed]) main page
* CDC: Current VISs ([link removed]) main page

Back to top (#Top)
------------------------------------------------------------
Recap: Vaccine Information Statements and translations released in August and September

IZ Express regularly provides readers with information about new and updated Vaccine Information Statements (VISs) and their translations.

On July 24, CDC released an updated interim VIS for Pediatric Multi-vaccines (Your Child's First Vaccines) ([link removed]) . Immunize.org recently provided the following translations.

Pediatric Multi-vaccines (Your Child’s First Vaccines) view in English ([link removed]) :
Arabic ([link removed]) Portuguese ([link removed])
Burmese ([link removed]) Russian ([link removed])
Chinese-Simplified ([link removed]) Somali ([link removed])
Chinese-Traditional ([link removed]) Spanish PDF ([link removed]) and RTF ([link removed])
Farsi ([link removed]) Tagalog ([link removed])
French ([link removed]) Vietnamese ([link removed])
Haitian Creole ([link removed])
Related Links
* Immunize​.org: Vaccine Information Statement ([link removed]) main page for VISs in up to 47 languages
* CDC: What's New with VISs ([link removed]) web page
* CDC: Current VISs ([link removed]) web page

Back to top (#Top)
------------------------------------------------------------
Featured Resources
------------------------------------------------------------
National Network of Immunization Coalitions’ webinar, “What You Need to Know about New RSV Immunizations for Children and Adults,” available for on-demand viewing 

On September 25, the National Network of Immunization Coalitions hosted a live, 1-hour webinar, What You Need to Know about New RSV Immunizations for Children and Adults ([link removed]) . During this webinar, CDC experts provided an overview of the burden of RSV on pediatric and older adult populations, and shared information about the new ACIP recommendations for protecting adults 60 years of age and older against RSV. They also discussed the new ACIP recommendations to prevent disease in infants, including maternal vaccination and the new long-acting monoclonal antibody for infants. An expert from the American Academy of Pediatrics (AAP) provided advice on billing and coding for administering the long-acting monoclonal antibody.

[link removed]

The webinar video is now available on the National Network of Immunization Coalitions website for on-demand viewing ([link removed]) . Please view and share this important webinar with your colleagues.
Back to top (#Top)

------------------------------------------------------------
Public Health Foundation and CDC create three videos to help clinicians differentiate “expiration date” and “beyond use date” for vaccines

The Public Health Foundation partnered with CDC to create the Vaccine Expiration Date and Beyond-Use Date or Time Video Series ([link removed]) . The three videos' topics (and length) are:
* What Is a Vaccine Expiration Date? ([link removed]) (3:48)
* What Is a Vaccine Beyond Use Date or Time (BUD)? ( ([link removed]) 3:55)
* The Difference between a Vaccine Expiration Date and Beyond Use Date or Time (BUD) ([link removed]) (6:16)

[link removed]

Training the vaccination workforce on the importance of monitoring vaccine expiration and beyond-use dates is crucial for inventory management and helps ensure the safety and efficacy of vaccines. The videos are part of the TRAIN Learning Network ([link removed]) TRAIN Learning Network ([link removed]) .
Back to top (#Top)
------------------------------------------------------------
Public Health Communications Collaborative offers social media graphics and messages to communicate key details about respiratory illness prevention

The Public Health Communications Collaborative (PHCC) created the Toolkit: Fall and Winter 2023 Vaccination Promotion ([link removed]) , to help communicate timely, effective, and consistent information about flu, COVID-19, and RSV vaccinations. Unbranded and available in English and Spanish, it is designed to communicate the most relevant information to the public. It includes, for example:
* Customizable social media sample posts ([link removed])
* Answers to frequently asked COVID-19 questions ([link removed])
* Messaging guide ([link removed]) (also available in Spanish ([link removed]) )

[link removed]

Related Links
* PHCC: Toolkit: Fall and Winter 2023 Vaccination Promotion ([link removed]) main page
* PHCC: Messaging: Fall and Winter 2023 Immunizations ([link removed]) main page

Back to top (#Top)
------------------------------------------------------------
Explore the www.Give2MenACWY​.org website to increase coverage for the MenACWY booster and other adolescent vaccinations

Immunize​.org's www.Give2MenACWY.org ([link removed]) website promotes the importance of adolescent vaccination, including the recommended MenACWY vaccine booster dose at age 16. Many teens are behind on vaccines because of the pandemic, so vaccine outreach is more important than ever.

Materials on this colorful website for healthcare professionals incorporate the 2020 ACIP meningococcal vaccine recommendations ([link removed]) and coverage statistics from CDC’s National Immunization Survey–Teen (NIS–Teen). One particularly popular resource on the site is the update Algorithm for MenACWY Immunization in Adolescents 11 through 18 Years of Age ([link removed]) .

[link removed]

The website is divided into five easy-to-access sections:
* Vaccinate Teens ([link removed]) – Teen vaccination schedules and tips for improving vaccination rates
* Give 2 Doses ([link removed]) – Tools to help improve second dose coverage of MenACWY vaccine
* 16-Year-Old Visit ([link removed]) – Resources to help providers and patients remember the important vaccines recommended for 16-year-olds
* Tools for Providers ([link removed]) – Tools to explain meningococcal ACWY vaccine recommendations and improve coverage for all adolescent vaccines
* Resources ([link removed]) – Links to print materials ([link removed]) , organizations ([link removed]) involved in adolescent vaccination, personal stories ([link removed]) about the importance of vaccination, and other resources ([link removed]) of interest

The site also categorizes materials ([link removed]) according to whether they are primarily of interest to providers, to adolescents, or to parents.

Visit Give2MenACWY.org ([link removed]) and enjoy browsing (and deploying) its bountiful resources.

Related Links
* Give2MenACWY.org ([link removed]) website
* Algorithm for MenACWY Immunization in Adolescents 11–18 Years of Age ([link removed])
* MenACWY: You're Not Done If You Give Just One: Give 2 Doses to Strengthen Protection ([link removed])
* Recommending MenACWY: What to Say and How to Say It ([link removed])
* Top 10 Ways to Improve Adolescent Immunization Rates ([link removed])
* Developing an Immunization Culture in Your Office ([link removed])
* Know Your Rates: Measuring Immunization Success in Your Practice ([link removed])
* You're 16: We Recommend These Vaccines for You ([link removed])
* Dear Colleague Letter: 16-Year-Old Patients: Make Sure They Receive Their Annual Well Visit and Vaccinations ([link removed]) – signed by six medical societies
* Ask the Experts: Meningococcal ACWY ([link removed])
* CDC: 2020 ACIP Meningococcal Vaccine Recommendations ([link removed])
* CDC: National, Regional, State, and Selected Local Area Vaccination Coverage among Adolescents Aged 13–17 Years — United States, 2020 ([link removed])
* CDC: Adolescent Vaccination Coverage in the U.S. ([link removed])

Back to top (#Top)
------------------------------------------------------------
Notable Publications
------------------------------------------------------------
“COVID-19 Vaccination Recommendations and Practices for Women of Reproductive Age, by Health Care Providers—Fall DocStyles Survey, United States, 2022” published in MMWR

CDC published COVID-19 Vaccination Recommendations and Practices for Women of Reproductive Age, by Health Care Providers—Fall DocStyles Survey, United States, 2022 ([link removed]) on September 29 in MMWR. A portion of the summary appears below.

Although most (82.9%) surveyed HCPs recommended that women of reproductive age stay up to date with COVID-19 vaccines, only 54.7% offered or administered the vaccine in their practice. HCPs were more likely to offer or administer COVID-19 vaccination on-site to pregnant patients if they also offered or administered influenza (adjusted prevalence ratio [aPR] = 5.5) and tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccines (aPR = 2.3).

Access the MMWR article in HTML ([link removed]) or PDF ([link removed]) .

Related Link
* MMWR's main page ([link removed]) provides access to the MMWR family of publications

Back to top (#Top)

------------------------------------------------------------
“Inequities in COVID-19 Vaccination Coverage among Pregnant Persons, by Disaggregated Race and Ethnicity—Massachusetts, May 2021–October 2022” published in MMWR

CDC published Inequities in COVID-19 Vaccination Coverage among Pregnant Persons, by Disaggregated Race and Ethnicity—Massachusetts, May 2021–October 2022 ([link removed]) on September 29 in MMWR. A portion of the summary appears below.

Among pregnant persons in the United States, Hispanic or Latino (Hispanic) and non-Hispanic Black or African American persons experience the highest COVID-19 rates and the lowest COVID-19 vaccination coverage. Aggregation of race and ethnicity data can obscure within-group diversity and inequities. . . .

Among 102,275 Massachusetts residents with pregnancies resulting in live birth during May 2021–October 2022, data disaggregation into 12 racial and 34 ethnic groups revealed inequities in COVID-19 vaccination coverage that were masked within all larger race and ethnicity groupings. . . .

Disaggregating race and ethnicity data can uncover within-group differences in COVID-19 vaccination coverage that might guide tailored public health messaging.

Access the MMWR article in HTML ([link removed]) or PDF ([link removed]) .

Related Link
* MMWR's main page ([link removed]) provides access to the MMWR family of publications

Back to top (#Top)
------------------------------------------------------------
“Effectiveness of Maternal mRNA COVID-19 Vaccination during Pregnancy against COVID-19–Associated Hospitalizations in Infants Aged <6 Months during SARS-CoV-2 Omicron Predominance—20 States, March 9, 2022–May 31, 2023” published in MMWR

CDC published Effectiveness of Maternal mRNA COVID-19 Vaccination during Pregnancy against COVID-19–Associated Hospitalizations in Infants Aged <6 Months during SARS-CoV-2 Omicron Predominance—20 States, March 9, 2022–May 31, 2023 ([link removed] ) on September 29 in MMWR. A portion of the summary appears below.

Infants aged <6 months are not eligible for COVID-19 vaccination and are at risk for COVID-19–associated complications. Maternal vaccination received during pregnancy could protect infants from COVID-19–related hospitalization. . . .

During the period of recent SARS-CoV-2 Omicron predominance, maternal receipt of an mRNA COVID-19 vaccine during pregnancy reduced the likelihood of COVID-19-related hospitalizations and serious complications among infants aged <6 months. . . .

Expectant mothers should remain current with COVID-19 vaccination to protect themselves and their infants from hospitalization and severe outcomes associated with COVID-19.

Access the MMWR article in HTML ([link removed] ) or PDF ([link removed]) .

Related Link
* MMWR's main page ([link removed]) provides access to the MMWR family of publications

Back to top (#Top)

------------------------------------------------------------
“Influenza, Tdap, and COVID-19 Vaccination Coverage and Hesitancy among Pregnant Women—United States, April 2023” published in MMWR

CDC published Influenza, Tdap, and COVID-19 Vaccination Coverage and Hesitancy among Pregnant Women—United States, April 2023 ([link removed]) on September 29 in MMWR. A portion of the summary appears below.

During the 2022–23 influenza season, 47.2% of women received influenza vaccination before or during pregnancy, 55.4% of women with a recent live birth received Tdap vaccination during pregnancy, and 27.3% of women received a COVID-19 bivalent booster vaccine before or during pregnancy. Pregnant women who received a provider recommendation for vaccination were less hesitant about influenza and Tdap vaccines. . . .

Promotion of efforts to improve vaccination coverage among pregnant women, such as provider recommendation for vaccination and informative conversations with patients to address vaccine hesitancy, could reduce adverse maternal and infant illness and death from vaccine-preventable diseases.

Access the MMWR article in HTML ([link removed]) or PDF ([link removed]) .

Related Link
* MMWR's main page ([link removed]) provides access to the MMWR family of publications

Back to top (#Top)
------------------------------------------------------------
Upcoming Events
------------------------------------------------------------
Today! Virtual: CDC briefing on fall and winter virus season with CDC Director Mandy K. Cohen on October 4 at 12:00 p.m. (ET).

CDC is hosting a briefing on the fall and winter virus season ([link removed]) from 12:00 to 1:30 p.m. (ET) on October 4. During the webinar, CDC Director Mandy K. Cohen, MD, MPH, will provide updates on the fall and winter virus season landscape. This will include a sneak peek at CDC’s new communications efforts to address the spread of influenza, COVID-19, and RSV and resources that will be available for partners.
Register for the webinar ([link removed]) .

Back to top (#Top)
------------------------------------------------------------
For more upcoming events, visit our Calendar of Events ([link removed]) .
Editorial Information
Editor-in-Chief
Kelly L. Moore, MD, MPH
Managing Editor
John D. Grabenstein, RPh, PhD
Associate Editor
Sharon G. Humiston, MD, MPH
Writer/Publication Coordinator
Taryn Chapman, MS
Courtnay Londo, MA
Style and Copy Editor
Marian Deegan, JD
Web Edition Managers
Arkady Shakhnovich
Jermaine Royes
Contributing Writer
Laurel H. Wood, MPA
Technical Reviewer
Kayla Ohlde

About IZ Express
Immunize​.org welcomes redistribution of this issue of IZ Express or selected articles.
When you do so, please add a note that Immunize​.org is the source of the material and provide a link to this issue ([link removed]) .

IZ Express is supported in part by Grant No. 1NH23IP922654 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of Immunize​.org and do not necessarily represent the official views of CDC.

IZ Express Disclaimer ([link removed])
ISSN: 2771-8085

This email was sent to [email protected] (mailto:[email protected])
why did I get this? ([link removed]) unsubscribe from this list ([link removed]) update subscription preferences ([link removed])
Immunize.org . 2136 Ford Parkway . Suite 5011 . Saint Paul, MN 55116 . USA